The management and outcome of bladder carcinoma in Ontario, 1982-1994

Cancer

Volumn 89, Issue 1, 2000, Pages 142-151

  Hayter, Charles R ^a,b   Paszat, Lawrence F ^a,b   Groome, Patti A ^a   Schulze, Karleen ^a   Mackillop, William J ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

Bladder carcinoma; Cystectomy; Outcomes research; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANADA; CANCER SURVIVAL; CYSTECTOMY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; CARCINOMA, TRANSITIONAL CELL; COMBINED MODALITY THERAPY; CYSTECTOMY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; ONTARIO; OUTCOME ASSESSMENT (HEALTH CARE); REGISTRIES; RETROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS;

EID: 0034235285     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20000701)89:1<142::AID-CNCR19>3.0.CO;2-4     Document Type: Article

References (19)

1. Canadian Cancer Statistics 1998. Toronto, Ontario: NCI Canada, 1999.
2. Sher HI, Shipley W, Herr H. Cancer of the bladder. In: De Vita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. Philadelphia: Lippincott-Raven, 1997:1300-22.
3. Levi F, La Vecchia C, Randimbison L, Franceschi S. Incidence of infiltrating cancer following superficial bladder carcinoma. Int J Cancer 1993;55:419-21.
4. Paulson DF. Critical review of radical cystectomy and indicators of prognosis. Semin Urol 1993;11:205-13.
5. Duncan W, Quilty PM. The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage X-ray therapy. Radiother Oncol 1986;7:299-310.
6. Gospodarowicz MK, Rider WD, Keen CW, Connolly JG, Jewett MAS, Cummings BJ, et al. Bladder cancer: long-term follow-up results of patients treated with radical radiation. Clin Oncol (R Coll Radiol) 1991;3:155-61.
7. Bloom HJG, Hendry WF, Wallace DM, Skeet RG. Treatment of T3 bladder cancer: controlled trial of pre-operative radiotherapy and radical cystectomy versus radical radiotherapy. Second report and review for the Clinical Trials Group, Institute of Urology. Br J Urol 1982;54:136-51.
8. Sell A, Jakobsen A, Nerstrom B, Sorensen BL, Steven K, Barlebo H. Treatment of advanced bladder cancer category T2, T3 and T4a. Scand J Urol Nephrol 1991;138:193-201.
9. Quilty PM, Duncan W. Primary radical radiotherapy for T3 transitional cell cancer of the bladder: an analysis of survival and control. Int J Radiat Oncol Biol Phys 1986;12:853-60.
10. Quilty PM, Duncan W, Chisholm GD, Fowler JW, Hargreave TB, Newsam JE, et al. Results of surgery following radical radiotherapy for invasive bladder cancer. Br J Urol 1986;58: 396-405.
11. Hayter CRR, Paszat LP, Groome PA, Schulze K, Mackillop WJ. A population-based study of the use and outcome of radical radiotherapy for invasive bladder cancer. Int J Radiat Oncol Biol Phys 1999;45:1239-45.
12. Holowaty EJ, Marrett LD, Fehringer G. Cancer incidence in Ontario: trends and regional variations in the 1980s. Toronto, Ontario: The Ontario Cancer Treatment and Research Foundation, Publications Ontario, 1995.
13. Messing EM, Young TB, Hunt VB, Gilchrist KW, Newton MA, Bram LL, et al. Comparison of bladder cancer outcome in men undergoing hematuria home screening versus those with standard clinical presentations. Urology 1995;45:387-97.
14. Kiemeney LALM, Coebergh JWW, Koper NP, van der Heijden LH, Pauwels RPE, Schapers RFM, et al. Bladder cancer incidence and survival in the South-eastern part of the Netherlands, 1975-1989. Eur J Cancer 1994;30A:1134-7.
15. Mackillop WJ, Dixon P, Zhou Y, Ago CT, Ege G, Hodson DI, et al. Variations in the management and outcome of non-small cell lung cancer in Ontario. Radiother Oncol 1994;32: 106-15.
16. Iscoe NA, Goel V, Wu K, Fehringer G, Holowaty EJ, Naylor CD. Variation in breast cancer surgery in Ontario. CMAJ 1994;150:345-52.
17. Paszat LP, Mackillop WJ, Groome PA, Zhang-Salomons J, Schulze K, Holowaty EJ. Radiotherapy for breast cancer in Ontario: rate variation associated with region, age and income. Clin Invest Med 1998;21:125-34.
18. Hayter CRR. Historical roots of current problems in cancer control. CMAJ 1998;158:1735-40.
19. Coppin C, Gospodarowicz MK, James K, Tannock IF, Zee B, Carson J, et al. Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. J Clin Oncol 1996;14:2901-7.